CD14+ monocyte levels in subgroups of acute coronary syndromes

İbrahіm Özdoğru(Erciyes University), Nihat Kalay(Erciyes University), Ali Doğan(Erciyes University), İbrahim Gül(Erciyes University), Mehmet Güngör Kaya(Erciyes University), Mehmet Tuğrul İnanç(Erciyes University), Namk Kemal Eryol(Institute of Cardiology)
Coronary Artery Disease
November 1, 2007
10.1097/mca.0b013e3282ef4e7c
Cited by 5

Related Papers

Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
|Journal of the American College of Cardiology|2006|715
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
|International Journal of Cardiology|2012|325
Protective Effects of Spironolactone Against Anthracycline-Induced Cardiomyopathy
|European Journal of Heart Failure|2014|259
Hematologic Parameters and Angiographic Progression of Coronary Atherosclerosis
|Angiology|2011|164
Cardiovascular Effects of Carbon Monoxide Poisoning
|The American Journal of Cardiology|2006|141